Intravides is a biotechnology startup based in Italy, founded in 2013. The company's mission is to revolutionize surgical procedures by creating an AR application for the OR. Their flagship product, Holosurgery, harnesses the power of augmented reality goggles to empower surgeons with strategic access to medical information and 3D surgical planning during operations. This is made possible through their patent-pending pipeline, enabling rapid and reliable 3D reconstruction of anatomy from CT scans or MRI data. Intravides recently secured a $10.00K Pre Seed Round investment on 06 December 2018, with the KAUST Innovation Fund as the contributing investor. This funding marks a key milestone in the company's journey, providing them with the resources to further develop and commercialize their innovative AR solutions for the surgical field. As the demand for advanced medical technologies continues to grow, Intravides stands to make a significant impact in the biotechnology sector with their cutting-edge augmented reality offerings.
No recent news or press coverage available for Intravides.